Senator Mike Lee Introduces the Biosimilar Red Tape Elimination Act to Eliminate Switching Study Requirement for Biosimilar Interchangeability | Venable LLP

On November 17, 2022, Senator Mike Lee (R-UT) introduced the “Biosimilar Red Tape Elimination Act” to increase biosimilar competition and reduce patient costs by prohibiting the FDA...

Related Keywords

,European Medicines Agency ,Regulatory Agency ,Senator Mike Lee ,Red Tape Elimination ,Biologics Price Competition ,Innovation Act ,First Interchangeable ,Switching Study ,Biosimilar Red Tape Elimination Act ,Biosimilars Approved ,Considered Interchangeable ,